Adoptive immunotherapy with engineered T cells expressing and HLA-A2 restricted affinity-enhanced TCR for LAGE-1 and NY-ESO-1 in patients with multiple myeloma following auto-SCT

Detalles Bibliográficos
Autores principales: Rapoport, Aaron P, Stadtmauer, Edward A, Vogl, Dan T, Weiss, Brendan, Binder-Scholl, Gwendolyn K, Smethurst, Dominic P, Finklestein, Jeffrey, Kulikovskaya, Irina, Gupta, Minnal, Brewer, Joanna E, Bennett, Alan D, Gerry, Andrew B, Pumphrey, Nick J, Tayton-Martin, Helen K, Ribeiro, Lilliam, Badros, Ashraf Z, Yanovich, Saul, Akpek, Gorgun, Kerr, Naseem, Philip, Sunita, Westphal, Sandra, Bruce, Levine L, Jakobsen, Bent K, June, Carl H, Kalos, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990335/
http://dx.doi.org/10.1186/2051-1426-1-S1-P30

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990335/
http://dx.doi.org/10.1186/2051-1426-1-S1-P30

Ejemplares similares